Composition, form of production and packaging
The solution for the sc administration is clear, colorless or light yellow in color, with a specific odor.
vaccine for the treatment of staphylococcal infections (peptidoglycan and teichoic acid complex, extracted from microbial cells by water-phenolic extraction) 1 ml
Auxiliary substances: phenol - (0.2 В± 0.05)%.
1 ml - ampoules (5) - packings the cellular contour (2) - packs cardboard.
1 ml - ampoules (10) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
The introduction of the drug in accordance with the approved scheme causes in vaccines the formation of a specific antimicrobial anti-staphylococcal immunity.
Treatment of pustular diseases of staphylococcal etiology:
- abscesses, furuncles and carbuncles of the skin;
- gordoleuma and other deep inflammations of the eyelids;
The vaccine is approved for use from 6 months of age.
The staphylococcal curative is injected subcutaneously into the shoulder area or the subscapular region.
The course of treatment for adults and children from 7 years of age consists of a single daily injection as follows:
1st day - 0.2 ml
Day 2 - 0.3 ml
Day 3 - 0.4 ml
4th day - 0.5 ml
Day 5 - 0.6 ml
Day 6 - 0.7 ml
7th day - 0.8 ml
Day 8 - 0.9 ml
Day 9 -1.0 ml
For children from 6 months to 7 years, the dose for the first injection is 0.1 ml. In the absence of the reaction, the drug is administered daily according to the scheme, sequentially increasing each dose by 0.1 ml (the second injection - 0.2 ml, the third - 0.3 ml, etc.) for 9 days.
Use of the vaccine for children aged 6 months to 7 years in addition must be agreed with the attending physician.
In case of prematurity (body weight at birth less than 2.5 kg), treatment is performed provided that the child reaches normal age indices.
Each subsequent dose of the drug is administered at a distance of 20-30 mm from the site of previous injections or into the other arm.
In diseases with common skin lesions that occur with relapses, it is advisable to conduct a second course of treatment according to the same schedule after 10-15 days.
With the development of a local or general reaction, the subsequent administration of the vaccine is carried out after the disappearance of the reaction at the same dose as the previous one. In the case of a pronounced reaction to the administration of the vaccine (an increase in body temperature to 38 В° C or higher, significant soreness in the inflammatory foci, infiltration at the site of administration of the vaccine more than 20 mm in diameter), at the discretion of the attending physician, the interval between injections may be extended to 2-3 days, repeat or decrease the dose with repeated injections.
The preparation is not suitable for use in ampoules with broken integrity, missing or poorly read marking, with changing physical properties (presence of opalescence, sediment), expired shelf life, improper storage.
Precautions for use
Opening of the ampoule with the vaccine and the vaccination procedure are carried out with strict adherence to the rules of aseptic and antiseptic. The vaccine in the opened ampoule should be used immediately.
Features of the drug at the first admission
After the first 2 injections in inflammatory foci soreness may increase.
Features of the drug when it is canceled
If you miss a dose or one or more doses, you should re-enter the last dose you took and then continue the treatment according to the scheme.
At the injection site, skin hyperemia and minor soreness may develop. In some patients, the administration of the drug may be accompanied by an increase in temperature of 0.5-1 В° C. If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.
- Children's age from birth to 6 months;
- rickets of II and III degrees;
- grade II and III hypotrophy;
- diseases of the endocrine system;
- liver and kidney disease;
- allergic diseases;
- Quincke's edema;
- bronchial asthma;
- common eczema;
- chronic bronchitis, unspecified;
- asthmatic bronchitis;
- diseases of the central nervous system;
- acute infectious (non-staphylococcal etiology) and non-infectious diseases, including the period of convalescence; chronic diseases in the stage of exacerbation or decompensation. Treatment with staphylococcal vaccine is carried out not earlier than a month after clinical recovery (remission).
PREGNANCY AND LACTATION
Contraindicated to carry out vaccination during pregnancy and lactation.
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindicated in kidney disease.
APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS
Contraindicated in liver diseases.
APPLICATION FOR CHILDREN
Contra-indication: child age from birth to 6 months
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to drive vehicles.
There were no symptoms of an overdose with the use of a staphylococcal vaccine.
TERMS OF RELEASE FROM PHARMACY
TERMS AND CONDITIONS OF STORAGE
In a dry, dark place at a temperature of 2 to 10 В° C. Keep out of the reach of children. Shelf life - 2 years.